Aadac - arylacetamide deacetylase Gene
Also Known as Aada
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 57300
Summary
Predicted to enable deacetylase activity; serine hydrolase activity; and triglyceride Lipase activity. Predicted to be involved in positive regulation of triglyceride catabolic process. Predicted to be integral component of membrane. Predicted to be active in endoplasmic reticulum membrane. Orthologous to human AADAC (arylacetamide deacetylase). [provided by Alliance of Genome Resources, Apr 2022]
Aadac Products (1)
| mRNA | Protein | Name |
|---|---|---|
| NM_020538.1 | NP_065413.1 | arylacetamide deacetylase |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
arylacetamide deacetylase |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(3)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS00017 | AADAC Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS18798 | Aadac Mouse Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-RS25287 | Aadac Rat Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service